Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of a New Electrochemical Dna Biosensor Based on Eu3+−Doped Nio for Determination of Amsacrine As an Anti-Cancer Drug: Electrochemical, Spectroscopic and Docking Studies Publisher Pubmed



Akbari Javar H1 ; Garkaninejad Z2 ; Dehghannoudeh G3 ; Mahmoudimoghaddam H3, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pharmaceutics Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Chemistry Department, Faculty of Science, Shahid Bahonar University of Kerman, Kerman, Iran
  3. 3. Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  4. 4. Environmental Health Engineering Research Center, Kerman University of Medical Sciences, Kerman, Iran

Source: Analytica Chimica Acta Published:2020


Abstract

The present research reported a new electrochemical biosensor based on ds-DNA/Eu3+ doped NiO/CPE to detect amsacrine. Therefore, UV–Vis spectrophotometry, docking, and differential pulse voltammetry (DPV) have been used to study the interactions between amsacrine and dsDNA. Then, experimental parameters affected DNA immobilization and interactions between amsacrine and ds-DNA have been optimized. Afterwards, guanine oxidation peak current of ds-DNA has been chosen as a signal to analyze amsacrine in a concentration ranging between 0.1 and 100.0 μM and finally, limit of detection (LOD) of 0.05 μM has been calculated at optimal condition. Ultimately, it was found that the suggested biosensor is able to determine amsacrine in human serum and urine samples successfully. © 2020 Elsevier B.V.